Oppenheimer Asset Management Inc. Has $725,000 Stock Holdings in Core Laboratories Inc. $CLB

Oppenheimer Asset Management Inc. cut its holdings in shares of Core Laboratories Inc. (NYSE:CLB) by 9.0% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 62,951 shares of the oil and gas company’s stock after selling 6,233 shares during the period. Oppenheimer Asset Management Inc. owned about 0.13% of Core Laboratories worth $725,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in CLB. Ariel Investments LLC increased its stake in shares of Core Laboratories by 7.4% in the 1st quarter. Ariel Investments LLC now owns 10,342,025 shares of the oil and gas company’s stock valued at $155,027,000 after acquiring an additional 709,455 shares in the last quarter. Hotchkis & Wiley Capital Management LLC acquired a new stake in Core Laboratories in the 1st quarter valued at $6,008,000. Fred Alger Management LLC grew its position in Core Laboratories by 32.4% in the 1st quarter. Fred Alger Management LLC now owns 736,853 shares of the oil and gas company’s stock valued at $11,045,000 after purchasing an additional 180,344 shares during the period. Nuveen LLC acquired a new stake in Core Laboratories in the 1st quarter valued at $2,573,000. Finally, Rice Hall James & Associates LLC grew its position in Core Laboratories by 71.2% in the 1st quarter. Rice Hall James & Associates LLC now owns 193,798 shares of the oil and gas company’s stock valued at $2,905,000 after purchasing an additional 80,595 shares during the period. 97.81% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

CLB has been the topic of a number of analyst reports. Stifel Nicolaus cut their price objective on shares of Core Laboratories from $13.00 to $12.00 and set a “hold” rating on the stock in a report on Wednesday, July 16th. Weiss Ratings raised shares of Core Laboratories from a “sell (d+)” rating to a “hold (c-)” rating in a report on Friday, October 24th. Zacks Research upgraded Core Laboratories from a “strong sell” rating to a “hold” rating in a research report on Friday, August 15th. Finally, Wall Street Zen upgraded Core Laboratories from a “sell” rating to a “hold” rating in a research report on Saturday, July 26th. Four research analysts have rated the stock with a Hold rating, Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $12.50.

Core Laboratories Stock Down 0.1%

Shares of Core Laboratories stock opened at $15.95 on Friday. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.76 and a current ratio of 2.37. Core Laboratories Inc. has a 52-week low of $9.72 and a 52-week high of $21.83. The stock has a market capitalization of $742.40 million, a price-to-earnings ratio of 23.80, a P/E/G ratio of 8.81 and a beta of 1.38. The company’s 50 day moving average price is $12.63 and its 200-day moving average price is $11.97.

Core Laboratories (NYSE:CLB) last announced its quarterly earnings results on Wednesday, October 22nd. The oil and gas company reported $0.22 EPS for the quarter, topping analysts’ consensus estimates of $0.19 by $0.03. The company had revenue of $134.52 million during the quarter, compared to analyst estimates of $130.92 million. Core Laboratories had a return on equity of 12.85% and a net margin of 6.21%.The firm’s revenue was up .1% on a year-over-year basis. During the same quarter last year, the firm posted $0.25 earnings per share. Core Laboratories has set its Q4 2025 guidance at 0.180-0.22 EPS. Equities research analysts forecast that Core Laboratories Inc. will post 0.96 EPS for the current year.

Core Laboratories Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, November 24th. Stockholders of record on Monday, November 3rd will be issued a dividend of $0.01 per share. The ex-dividend date is Monday, November 3rd. This represents a $0.04 annualized dividend and a dividend yield of 0.3%. Core Laboratories’s dividend payout ratio (DPR) is presently 5.97%.

About Core Laboratories

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.